Glaxosmithkline Pharmaceuticals has informed that the Board of Directors have jointly authorized the enclosed personnel of the Company, for the purpose of determining the materiality of any event or transaction for the purpose of making disclosures.
The above information is a part of company’s filings submitted to BSE.